aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

Also called NCT02513797

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02513797
Other papers using this trial's data
  • Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial Circulation. Arrhythmia and electrophysiology, 2026-08 DOI, PubMed 42517227
  • Pulmonary Vein Isolation With or Without Left Atrial Appendage Ligation in Atrial Fibrillation: The aMAZE Randomized Clinical Trial JAMA, 2024-04-02 DOI, PubMed 38563835, PMC10988350 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02513797. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2021-04-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation
Acronym
aMAZE
Intervention (Device)
LARIAT + PVI
Intervention (Device)
Pulmonary Vein Isolation
Lead sponsor
AtriCure, Inc. (class: industry)

Record details

Record id
cardio:ct-nct02513797
Content hash
4c20542e2811ed534c1a30b129ddc19ea8ce15b5f84439b2d9c6dbc9d1fdd63f